QIAGEN Partners With International Panel Physicians Association To Increase Awareness Of Tuberculosis Screening Requirements
QIAGEN Partners With International Panel Physicians Association To Increase Awareness Of Tuberculosis Screening Requirements
QIAGEN与国际专家小组医师协会合作，提高对结核筛查要求的认识
QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA))))) today announced a partnership with the International Panel Physicians Association (IPPA) to support and educate panel physicians around the globe on the latest tuberculosis (TB) screening requirements. A special focus will be on the new Interferon Gamma Release Assay (IGRA) requirements and the associated benefits for patients and healthcare providers.
QIAGEN（纽约证券交易所代码：QGEN，法兰克福主要标准：QIA）））今天宣布与国际专家小组医师协会（IPPA）建立合作伙伴关系，以支持和教育全球各地的专科医生了解最新的结核病（TB）筛查要求。将特别关注新的干扰素伽玛释放试验（IGRA）要求以及患者和医疗保健提供者的相关益处。
This collaboration follows the U.S. Centers for Disease Control and Prevention (CDC) updating its guidelines for new TB screening requirements for immigrants to the United States. Together, QIAGEN and IPPA are committed to promoting the use of IGRA testing, such as QIAGEN...
此次合作是在美国疾病控制与预防中心（CDC）更新其针对移民到美国的新结核病筛查要求的指...
登录免费看全文
登录/注册